Home Merck to buy Idenix Pharma for $3.85 billion
 

Keywords :   


Merck to buy Idenix Pharma for $3.85 billion

2014-06-09 15:33:35| Biotech - Topix.net

Merck & Co. says the Cambridge, Massachusetts, company has built a promising portfolio of hepatitis C treatments, including three in clinical testing Merck will spend $24.50 per share in cash for each share, which closed at $7.23 Friday.

Tags: buy billion pharma merck

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news

»
05.10Tropical Depression Fourteen Graphics
05.10Tropical Depression Fourteen Forecast Discussion Number 1
05.10Tropical Depression Fourteen Wind Speed Probabilities Number 1
05.10Tropical Depression Fourteen Public Advisory Number 1
05.10Summary for Tropical Depression Fourteen (AT4/AL142024)
05.10Tropical Depression Fourteen Forecast Advisory Number 1
05.10Hurricane Kirk Graphics
05.10Hurricane Kirk Forecast Discussion Number 25
More »